Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy.
Yusuf IlhanGokhan UcarMehmet Nuri BaserHalil Goksel GuzelSafa Can EfilBilgin DemirDuygu Ercan UzundalTuba KaracelikNadiye SeverOnur Yazdan BalcikHayati ArvasIbrahim KaradagAhmet KadiogluÖmer Burak EkinciCengiz KaracinZuhat UrakciOsman KostekMelek Karakurt EryilmazOzan YaziciMehmet Ali Nahit SendurBanu OzturkDogan UncuYakup ErgünPublished in: Expert opinion on pharmacotherapy (2024)
G-CSF prophylaxis can be safely used in ES-SCLC patients undergoing carboplatin plus etoposide and atezolizumab regimen without significantly altering efficacy or increasing toxicity.